Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2448079
Max Phase: Preclinical
Molecular Formula: C25H32Cl2N4O8S
Molecular Weight: 583.06
Molecule Type: Small molecule
Associated Items:
ID: ALA2448079
Max Phase: Preclinical
Molecular Formula: C25H32Cl2N4O8S
Molecular Weight: 583.06
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: C[C@H](N[C@@H](CCc1ccccc1)C(=O)O)C(=O)N(CCCNC(=O)c1ccc(Cl)c(S(N)(=O)=O)c1)CC(=O)O.Cl
Standard InChI: InChI=1S/C25H31ClN4O8S.ClH/c1-16(29-20(25(35)36)11-8-17-6-3-2-4-7-17)24(34)30(15-22(31)32)13-5-12-28-23(33)18-9-10-19(26)21(14-18)39(27,37)38;/h2-4,6-7,9-10,14,16,20,29H,5,8,11-13,15H2,1H3,(H,28,33)(H,31,32)(H,35,36)(H2,27,37,38);1H/t16-,20-;/m0./s1
Standard InChI Key: OGHHZHFGNUQZHL-XXRBRTKDSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 583.06 | Molecular Weight (Monoisotopic): 582.1551 | AlogP: 1.08 | #Rotatable Bonds: 15 |
Polar Surface Area: 196.20 | Molecular Species: ZWITTERION | HBA: 7 | HBD: 5 |
#RO5 Violations: 1 | HBA (Lipinski): 12 | HBD (Lipinski): 6 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 1.78 | CX Basic pKa: 9.43 | CX LogP: -1.48 | CX LogD: -4.60 |
Aromatic Rings: 2 | Heavy Atoms: 39 | QED Weighted: 0.19 | Np Likeness Score: -1.05 |
1. Barton JN, Piwinski JJ, Skiles JW, Regan JR, Menard PR, Desai R, Golec FS, Reilly LW, Goetzen T, Ueng SN.. (1990) Angiotensin-converting enzyme inhibitors. 9. Novel [[N-(1-carboxy-3-phenylpropyl)amino]acyl]glycine derivatives with diuretic activity., 33 (6): [PMID:2342054] [10.1021/jm00168a012] |
Source(1):